John T. Curnutte, Executive Vice President at PORTOLA PHARMACEUTICALS INC (PTLA), sold 50,000 shares at $55.47 ($2.9M) on 2017-06-26, disclosed to the SEC on 2017-06-28.
Open-market sale of $2.9M PTLA by Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.47 | 6,159 | $342K | 11.9% |
| 2 | $56.71 | 11,356 | $644K | 22.4% |
| 3 | $57.24 | 10,729 | $614K | 21.4% |
| 4 | $58.35 | 17,954 | $1.0M | 36.5% |
| 5 | $59.33 | 3,802 | $226K | 7.9% |
| Total | $57.46 avg | 50,000 |
| $2.9M |
| 100% |
| Filing → |
| PTLA | SELL | 2017-06-28 | $3.5M | — | Filing → |
| PTLA | SELL | 2015-07-15 | $500K | — | Filing → |
| PTLA | SELL | 2015-06-22 | $475K | — | Filing → |